Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Drug Eluting Stent Market, by Application
1.4.2 Europe Drug Eluting Stent Market, by Coating Type
1.4.3 Europe Drug Eluting Stent Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Europe Drug Eluting Stent Market by Application
4.1 Europe Coronary Artery Disease Market by Country
4.2 Europe Peripheral Artery Disease Market by Country
Chapter 5. Europe Drug Eluting Stent Market by Coating Type
5.1 Europe Polymer-based Coating Market by Country
5.2 Europe Drug Eluting Stent Market by Polymer-based Coating Type
5.2.1 Europe Non-biodegradable Polymers Market by Country
5.2.2 Europe Biodegradable Polymers Market by Country
5.3 Europe Polymer-free Coating Market by Country
5.4 Europe Drug Eluting Stent Market by Polymer-free Coating Type
5.4.1 Europe Micro Porous Surface Market by Country
5.4.2 Europe Micro Structured Surface Market by Country
5.4.3 Europe Slotted Tubular Surface Market by Country
5.4.4 Europe Nanoporous Surface Market by Country
Chapter 6. Europe Drug Eluting Stent Market by Country
6.1 Germany Drug Eluting Stent Market
6.1.1 Germany Drug Eluting Stent Market by Application
6.1.2 Germany Drug Eluting Stent Market by Coating Type
6.1.2.1 Germany Drug Eluting Stent Market by Polymer-based Coating Type
6.1.2.2 Germany Drug Eluting Stent Market by Polymer-free Coating Type
6.2 UK Drug Eluting Stent Market
6.2.1 UK Drug Eluting Stent Market by Application
6.2.2 UK Drug Eluting Stent Market by Coating Type
6.2.2.1 UK Drug Eluting Stent Market by Polymer-based Coating Type
6.2.2.2 UK Drug Eluting Stent Market by Polymer-free Coating Type
6.3 France Drug Eluting Stent Market
6.3.1 France Drug Eluting Stent Market by Application
6.3.2 France Drug Eluting Stent Market by Coating Type
6.3.2.1 France Drug Eluting Stent Market by Polymer-based Coating Type
6.3.2.2 France Drug Eluting Stent Market by Polymer-free Coating Type
6.4 Russia Drug Eluting Stent Market
6.4.1 Russia Drug Eluting Stent Market by Application
6.4.2 Russia Drug Eluting Stent Market by Coating Type
6.4.2.1 Russia Drug Eluting Stent Market by Polymer-based Coating Type
6.4.2.2 Russia Drug Eluting Stent Market by Polymer-free Coating Type
6.5 Spain Drug Eluting Stent Market
6.5.1 Spain Drug Eluting Stent Market by Application
6.5.2 Spain Drug Eluting Stent Market by Coating Type
6.5.2.1 Spain Drug Eluting Stent Market by Polymer-based Coating Type
6.5.2.2 Spain Drug Eluting Stent Market by Polymer-free Coating Type
6.6 Italy Drug Eluting Stent Market
6.6.1 Italy Drug Eluting Stent Market by Application
6.6.2 Italy Drug Eluting Stent Market by Coating Type
6.6.2.1 Italy Drug Eluting Stent Market by Polymer-based Coating Type
6.6.2.2 Italy Drug Eluting Stent Market by Polymer-free Coating Type
6.7 Rest of Europe Drug Eluting Stent Market
6.7.1 Rest of Europe Drug Eluting Stent Market by Application
6.7.2 Rest of Europe Drug Eluting Stent Market by Coating Type
6.7.2.1 Rest of Europe Drug Eluting Stent Market by Polymer-based Coating Type
6.7.2.2 Rest of Europe Drug Eluting Stent Market by Polymer-free Coating Type
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Mergers & Acquisition:
7.1.6 SWOT Analysis
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Terumo Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations & Agreements:
7.3.6 SWOT Analysis
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Trials and Approvals:
7.4.5.2 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.5.3 SWOT Analysis
7.6 Cook Medical, Inc. (Cook Group)
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 B. Braun Melsungen AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Biotronik SE & Co. KG
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Lepu Medical Technology Co., Ltd
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Alvimedica
7.10.1 Company Overview
7.10.2 SWOT Analysis
Unique Offerings 